Overview
Perimembranous ventricular septal defect (pmVSD) is a common congenital heart defect characterized by an abnormal opening in the membranous septum between the left and right ventricles. This condition accounts for approximately 70-80% of all ventricular septal defects and is particularly prevalent in infants and young children 1. Clinically significant pmVSDs can lead to symptoms such as dyspnea, tachypnea, failure to thrive, and recurrent respiratory infections due to left-to-right shunting and potential pulmonary hypertension. Early intervention is crucial as untreated cases may progress to irreversible heart failure or Eisenmenger syndrome. The management of pmVSDs has evolved from traditional open-heart surgery to minimally invasive transcatheter approaches, significantly reducing procedural risks and improving outcomes in pediatric patients 135. Understanding the nuances of diagnosis and treatment is essential for optimizing patient care and minimizing complications in day-to-day practice.Pathophysiology
The pathophysiology of pmVSDs arises from developmental anomalies during cardiac septation, specifically involving the fusion of the muscular and membranous septa. Typically, the membranous septum, formed by the fusion of the bulbar ridges, fails to close properly, resulting in a defect adjacent to the tricuspid valve. This defect allows for significant shunting of blood from the left ventricle to the right ventricle, increasing the workload on both ventricles and potentially leading to volume overload and hypertrophy 1. Over time, chronic volume overload can exacerbate right ventricular dilation and pulmonary hypertension, while left ventricular pressures may rise due to compensatory mechanisms. The hemodynamic consequences can manifest clinically as symptoms of heart failure and may necessitate early intervention to prevent long-term sequelae 1.Epidemiology
Perimembranous VSDs are among the most frequently encountered congenital heart defects, with an estimated incidence ranging from 0.4 to 1.3 per 1000 live births 1. They predominantly affect infants and young children, with a slight male predominance observed in some studies. Geographic variations exist, but no significant global trends indicate a marked increase or decrease in prevalence over recent decades. Risk factors include genetic predisposition and certain maternal exposures during pregnancy, though these associations are not definitively established. The condition's high prevalence underscores the importance of early detection and timely intervention to mitigate long-term cardiovascular complications 1.Clinical Presentation
Children with pmVSDs often present with nonspecific symptoms such as tachypnea, feeding difficulties, poor weight gain, and recurrent respiratory infections, especially in moderate to large defects. More severe cases may exhibit signs of heart failure, including diaphoresis, cyanosis, and syncope. Red-flag features include rapid progression of symptoms, signs of pulmonary hypertension (e.g., loud pulmonic component of the second heart sound, peripheral edema), and evidence of Eisenmenger syndrome (cyanosis, clubbing). These clinical presentations necessitate prompt evaluation to differentiate from other congenital heart defects and guide appropriate management 12.Diagnosis
The diagnostic approach for pmVSDs involves a combination of clinical evaluation and imaging techniques. Key diagnostic criteria include:Clinical Assessment: History of symptoms suggestive of heart failure or recurrent respiratory issues in infants.
Echocardiography: Essential for confirming the presence and size of the defect. Doppler echocardiography helps assess shunt direction and magnitude.
- Specific Criteria:
- Defect Location: Perimembranous location adjacent to the tricuspid valve.
- Size: Typically defined as moderate to large (e.g., ≥6 mm in diameter).
- Shunt: Left-to-right shunt with potential for increased pulmonary blood flow.
Cardiac Catheterization: Reserved for complex cases or when transcatheter closure is being considered, to assess hemodynamics and defect characteristics more precisely.
Differential Diagnosis:
- Atrial Septal Defects (ASD): Typically located in the upper septum, with different shunt dynamics.
- Muscular VSDs: Located more peripherally, often smaller and less symptomatic.
- Tetralogy of Fallot: Characterized by right ventricular outflow tract obstruction, cyanosis, and specific ECG findings.Management
Surgical Closure
Indications: Large or symptomatic pmVSDs in older children or those not amenable to transcatheter closure.
Technique: Via median sternotomy, using a mattress stitch or other suturing techniques to close the defect directly.
- Specifics:
- Suturing Method: Mattress stitch for larger defects to ensure secure closure 2.
- Complications Monitoring: Postoperative monitoring for arrhythmias, complete heart block, and residual shunts.Transcatheter Closure
Indications: Symptomatic or large pmVSDs in pediatric patients, particularly those weighing less than 10 kg.
Technique: Utilizing devices like the Amplatzer Duct Occluder-I (ADO-I) via various approaches.
- LV Mid-Cavity Approach:
- Procedure Details:
- Device Selection: ADO-I device sized 1-2 mm larger than the defect diameter.
- Steps: Crossing from RV, positioning in LV mid-cavity, deployment under fluoroscopy.
- Monitoring: Transthoracic echocardiography (TTE) and angiography for final assessment.
- Other Approaches:
- Peratrial Technique: Using a probe-assisted delivery system through a right parasternal incision 5.
- Ultra-Minimal Transcostal Incision: Minimally invasive approach guided by TEE 3.Contraindications
Severe Pulmonary Hypertension: High risk of paradoxical embolization.
Anatomical Constraints: Defects too large or complex for device closure.Complications
Acute Complications:
- Device Embolization: Risk during transcatheter procedures.
- Arrhythmias: Including complete heart block and bundle branch blocks 2.
- Residual Shunt: Potential for incomplete closure requiring further intervention.
Long-Term Complications:
- Aortic Regurgitation: Device impingement on the aortic valve.
- Valve Distortion: Impact on coaptation mechanism leading to functional valve issues.
- Reintervention: Need for repeat procedures due to device malfunction or residual defects.
- When to Refer: Persistent symptoms, device-related complications, or hemodynamic instability warrant specialist referral 1235.Prognosis & Follow-up
The prognosis for patients with successfully closed pmVSDs is generally favorable, with most achieving normal cardiac function and growth. Key prognostic indicators include:
Initial Defect Size: Larger defects may have a higher risk of residual shunting or complications.
Timing of Closure: Early intervention correlates with better outcomes.
Follow-Up Intervals: Regular echocardiograms at 1-3 months post-procedure, then annually to monitor for residual shunts, device function, and cardiac function.
Monitoring: Continued surveillance for signs of pulmonary hypertension and arrhythmias.Special Populations
Pediatrics
Age Considerations: Transcatheter closure is increasingly favored in infants and young children due to reduced morbidity compared to surgery.
Weight Limitations: Device size and procedural risks necessitate careful patient selection based on weight and defect characteristics 135.Comorbidities
Pulmonary Hypertension: Surgical closure may be preferred due to higher risks associated with transcatheter approaches.
Concurrent Cardiac Defects: Multidisciplinary management is essential, considering the complexity of combined defects.Key Recommendations
Early Diagnosis and Intervention: Prompt echocardiography to identify and assess pmVSDs, especially in symptomatic infants 1.
Transcatheter Closure for Suitable Patients: Consider transcatheter closure using devices like ADO-I for symptomatic or large pmVSDs in pediatric patients, particularly those weighing less than 10 kg 135.
Surgical Closure for Complex Cases: Use surgical techniques such as mattress stitching for large or complex defects not amenable to transcatheter closure 2.
Close Postoperative Monitoring: Regular follow-up with echocardiography to assess device position, residual shunts, and cardiac function 1235.
Avoid Transcatheter Closure in Severe Pulmonary Hypertension: High risk of complications; surgical closure may be safer 2.
Use of Advanced Techniques: Employ minimally invasive approaches like ultra-minimal transcostal incisions when feasible 3.
Multidisciplinary Care: Involve pediatric cardiologists, cardiac surgeons, and interventional cardiologists for comprehensive management 1235.
Patient Selection Based on Defect Characteristics: Tailor closure method based on defect size, location, and patient anatomy 135.
Continuous Monitoring for Arrhythmias: Postoperative monitoring for potential arrhythmias and conduction abnormalities 2.
Long-Term Follow-Up: Schedule regular echocardiograms to ensure sustained closure and monitor for late complications 1235.(Evidence: Strong) 1235
(Evidence: Moderate) 135
(Evidence: Expert opinion) 1
References
1 Ghosh S, Mukherji A, Chattopadhyay A. Percutaneous closure of moderate to large perimembranous ventricular septal defect in small children using left ventricular mid-cavity approach. Indian heart journal 2020. link
2 Shi G, Chen H, Sun Q, Zhang H, Zheng J. Mattress Stitch--A Modified Shallow Stitching in the Surgical Closure of Large Perimembranous Ventricular Septal Defect in Infants. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 2015. link
3 Gao Z, Yu J, Zhang Z, Li J, Yu J. Perimembranous ventricular septal defect closure via ultra-minimal trans intercostal incision in children. Journal of cardiac surgery 2021. link
4 Zhu G, Yuan Q, Hock Yeo J, Nakao M. Thermal treatment of expanded polytetraflu-oroethylene (ePTFE) membranes for reconstruction of a valved conduit. Bio-medical materials and engineering 2015. link
5 Hongxin L, Zhang N, Wenbin G, Zhang WL, Wang ZJ, Liang F et al.. Peratrial device closure of perimembranous ventricular septal defects through a right parasternal approach. The Annals of thoracic surgery 2014. link